Last reviewed · How we verify

NCT03500770

Lyme Disease Patients With Memory Problems

Suspended NA Last updated 18 April 2018
What this trial tests

NA trial testing Transcranial Direct Current Stimulator in Lyme Disease in 15 participants. Suspended.

Timeline
20 February 2019
Primary endpoint
30 December 2020
31 December 2020

Quick facts

Lead sponsorSpaulding Rehabilitation Hospital
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment15
Start date20 February 2019
Primary completion30 December 2020
Estimated completion31 December 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Spaulding Rehabilitation Hospital

Who can join

18 and older, any sex, with Lyme Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this study is to see if a device known as Transcranial Direct Current Stimulator (tDCS) is helpful in reducing persistent symptoms after Lyme disease treatment. Some of these symptoms include problems with memory, fatigue or pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lyme Disease

Currently open trials in the same condition.

Other Spaulding Rehabilitation Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03500770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing